MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

No Stability Information

Betnovate 0.1% scalp application (GlaxoSmithKline UK Ltd)

Explore other Betamethasone formulations Explore other Betamethasone valerate 0.1% scalp application suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Betnovate 0.1% scalp application (Sigma Pharmaceuticals Plc)

Explore other Betamethasone formulations Explore other Betamethasone valerate 0.1% scalp application suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Bettamousse 0.1% cutaneous foam (Lexon (UK) Ltd)

Explore other Betamethasone formulations Explore other Betamethasone 0.1% foam suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Bettamousse 0.1% cutaneous foam (Necessity Supplies Ltd)

Explore other Betamethasone formulations Explore other Betamethasone 0.1% foam suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Bettamousse 0.1% cutaneous foam (RPH Pharmaceuticals AB)

Explore other Betamethasone formulations Explore other Betamethasone 0.1% foam suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Bettamousse 0.1% cutaneous foam (Sigma Pharmaceuticals Plc)

Explore other Betamethasone formulations Explore other Betamethasone 0.1% foam suppliers

Stability Notes

There are no stability notes available for this medicine.

Incompatible

Bexarotene 75mg capsules (Advanz Pharma)

Explore other Bexarotene formulations Explore other Bexarotene 75mg capsules suppliers

Stability Notes

Cytotoxic medicine. Not recommended due to handler risk.

Incompatible

Bexarotene 75mg capsules (Celix Pharma Ltd)

Explore other Bexarotene formulations Explore other Bexarotene 75mg capsules suppliers

Stability Notes

Cytotoxic medicine. Not recommended due to handler risk.

Incompatible

Bexarotene 75mg capsules (Genus Pharmaceuticals Ltd)

Explore other Bexarotene formulations Explore other Bexarotene 75mg capsules suppliers

Stability Notes

Cytotoxic medicine. Not recommended due to handler risk.

No Stability Information

Beyonttra 356mg tablets (Bayer Plc)

Explore other Acoramidis formulations Explore other Acoramidis 356mg tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Bezafibrate 200mg tablets (A A H Pharmaceuticals Ltd)

Explore other Bezafibrate formulations Explore other Bezafibrate 200mg tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Bezafibrate 200mg tablets (Alliance Healthcare (Distribution) Ltd)

Explore other Bezafibrate formulations Explore other Bezafibrate 200mg tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Bezafibrate 200mg tablets (Noumed Life Sciences Ltd)

Explore other Bezafibrate formulations Explore other Bezafibrate 200mg tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Bezafibrate 200mg tablets (Teva UK Ltd)

Explore other Bezafibrate formulations Explore other Bezafibrate 200mg tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Bezafibrate 400mg modified-release tablets (Teva UK Ltd)

Explore other Bezafibrate formulations Explore other Bezafibrate 400mg modified-release tablets suppliers

Stability Notes

There are no stability notes available for this medicine.
Print this list

Compatible

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.

Compatible with caution

Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.

Incompatible

Medicines under this category are not suitable for use inside MCAs.

No Stability Information

We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.